LU84739A1 - Nouveaux antibiotiques de type carbapenem - Google Patents

Nouveaux antibiotiques de type carbapenem Download PDF

Info

Publication number
LU84739A1
LU84739A1 LU84739A LU84739A LU84739A1 LU 84739 A1 LU84739 A1 LU 84739A1 LU 84739 A LU84739 A LU 84739A LU 84739 A LU84739 A LU 84739A LU 84739 A1 LU84739 A1 LU 84739A1
Authority
LU
Luxembourg
Prior art keywords
carbon atoms
alkyl
atoms
group
radicals
Prior art date
Application number
LU84739A
Other languages
English (en)
French (fr)
Inventor
Choung Un Kim
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU84739A1 publication Critical patent/LU84739A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU84739A 1982-04-08 1983-04-07 Nouveaux antibiotiques de type carbapenem LU84739A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36662782A 1982-04-08 1982-04-08
US36662782 1982-04-08

Publications (1)

Publication Number Publication Date
LU84739A1 true LU84739A1 (fr) 1983-12-05

Family

ID=23443823

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84739A LU84739A1 (fr) 1982-04-08 1983-04-07 Nouveaux antibiotiques de type carbapenem

Country Status (25)

Country Link
JP (1) JPS58188887A (da)
KR (1) KR880001055B1 (da)
AT (1) AT383126B (da)
AU (1) AU567092B2 (da)
BE (1) BE896407A (da)
CA (1) CA1198440A (da)
CH (1) CH661927A5 (da)
DE (1) DE3312517A1 (da)
DK (1) DK155983A (da)
ES (1) ES8405399A1 (da)
FI (1) FI74009C (da)
FR (1) FR2524888B1 (da)
GB (1) GB2118183B (da)
GR (1) GR78822B (da)
HU (1) HU190716B (da)
IE (1) IE55225B1 (da)
IL (1) IL68295A0 (da)
IT (1) IT1168854B (da)
LU (1) LU84739A1 (da)
MY (1) MY8700945A (da)
NL (1) NL8301193A (da)
OA (1) OA07395A (da)
PT (1) PT76518B (da)
SE (1) SE460197B (da)
ZA (1) ZA832411B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
AT396473B (de) * 1984-10-02 1993-09-27 Bristol Myers Squibb Co Verfahren zur herstellung von neuen carbapenemderivaten
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
DK165280A (da) * 1979-04-19 1980-10-20 Merck & Co Inc Fremgangsmaade til fremstilling af 2- og 6-substituerede 1-carbadethiapen-2-em-3-carboxylsyrer og mellemprodukter til brug ved udoevelse af fremgangsmaaden
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
HU185493B (en) * 1981-12-30 1985-02-28 Richter Gedeon Vegyeszet Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptene derivatives
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics

Also Published As

Publication number Publication date
KR840004429A (ko) 1984-10-15
AT383126B (de) 1987-05-25
KR880001055B1 (ko) 1988-06-18
ZA832411B (en) 1983-12-28
CA1198440A (en) 1985-12-24
FI74009B (fi) 1987-08-31
FR2524888A1 (fr) 1983-10-14
MY8700945A (en) 1987-12-31
AU567092B2 (en) 1987-11-12
FR2524888B1 (fr) 1985-12-13
AU1319883A (en) 1983-10-13
BE896407A (fr) 1983-10-07
IT1168854B (it) 1987-05-20
GB2118183A (en) 1983-10-26
GB2118183B (en) 1985-11-27
IE830800L (en) 1983-10-08
GR78822B (da) 1984-10-02
ES521224A0 (es) 1984-06-01
IT8348061A0 (it) 1983-04-07
IE55225B1 (en) 1990-07-04
FI831135L (fi) 1983-10-09
DE3312517A1 (de) 1983-10-20
ES8405399A1 (es) 1984-06-01
NL8301193A (nl) 1983-11-01
ATA125583A (de) 1986-10-15
FI74009C (fi) 1987-12-10
GB8309505D0 (en) 1983-05-11
DK155983D0 (da) 1983-04-07
SE8301928L (sv) 1983-12-02
OA07395A (fr) 1984-06-30
DK155983A (da) 1983-10-09
JPH0524156B2 (da) 1993-04-06
JPS58188887A (ja) 1983-11-04
SE460197B (sv) 1989-09-18
IL68295A0 (en) 1983-07-31
CH661927A5 (de) 1987-08-31
FI831135A0 (fi) 1983-04-05
HU190716B (en) 1986-10-28
DE3312517C2 (da) 1991-10-31
PT76518B (en) 1986-02-06
PT76518A (en) 1983-05-01
SE8301928D0 (sv) 1983-04-07

Similar Documents

Publication Publication Date Title
FR2528847A1 (fr) Produits nouveaux de la classe des carbapenems et leur application en tant qu'antibiotiques
EP0247431B1 (de) Substituierte 6-Hydroxymethylcarbapenem-Antibiotika, Verfahren zu ihrer Herstellung und ihre Verwendung
CH657854A5 (fr) Derives de carbapenem, compositions pharmaceutiques les contenant, composes pour leur preparation, et leurs procedes de production.
EP0301394B1 (de) Stabile Oxapenem- 3-carbonsäuren
FR2533568A1 (fr) Nouveaux antibiotiques de la classe des carbapenems, et leur application pharmaceutique
LU84739A1 (fr) Nouveaux antibiotiques de type carbapenem
AT395590B (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
FR2542316A1 (fr) Procede de preparation de derives carbapenem, nouveaux intermediaires de synthese et procede de preparation de ces intermediaires
EP0362622B1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel
BE848545A (fr) Derives n-methylene substitues de thienamycine,
CH640236A5 (en) 3-(2-Aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2 -carboxylic acid and process for its preparation
FR2526798A1 (fr) Derives de peneme, leur procede de preparation et compositions therapeutiques les contenant
LU86678A1 (fr) Carbapenemes portant en position 2 un substituant heterothioalcoylthio quaternise
BE897854A (fr) Derives de carbapeneme antibiotiques
LU86105A1 (fr) Carbapenemes antibiotiques
DE69909098T2 (de) C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren
JPH05194528A (ja) 新規な1−オキサペネム−3−カルボン酸類及びそのβ−ラクタマーゼ阻害薬としての用途
LU85570A1 (fr) Nouveaux derives du carbapeneme,leur preparation et leur utilisation comme medicaments
FR2587704A1 (fr) Antibiotiques a base de carbapenem
BE897086A (fr) Produits nouveaux de la classe des carbapenems et leur application en tant qu'antibiotiques
BE899094A (fr) Procede de preparation de derives carbapenem, nouveaux intermediaires de synthese et procede de preparation de ces intermediaires.
AT381942B (de) Verfahren zur herstellung neuer carbapenem-derivate
FR2541279A1 (fr) Derives de l'acide 1-aza-7-oxo-bicyclo(3.2.0)-hept-2-ene-2-carboxylique
LU85535A1 (fr) Procede de preparation de carbapenemes
LU86410A1 (fr) Procede de preparation de carbapenemes